Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sekisui Chem Of Japan To Try Buy Of U.S. American Diagnostica

This article was originally published in PharmAsia News

Executive Summary

A Japanese chemical company plans to buy American Diagnostica, a mid-size U.S. maker of diagnostics. The acquisition would give Sekisui Chemical an entry into the U.S. diagnostics market. Sekisui plans to buy all outstanding shares through its Sekisui America subsidiary at a price not disclosed, but said to be more than $30 million. The acquisition would provide Sekisui an opening to sell its own products for diagnosing thrombosis and measuring cholesterol. ADI products would be marketed by Sekisui in Japan and China. (Click here for more - a subscription may be required
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071084

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel